MARYLINE ONGANGI: Open Payments
NPI 1215217351 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 45 payments from 12 companies in 2025. Trend: 2023 $898 · 2024 $794 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $239 |
| ABBVIE INC. | 8 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $85 |
| Abbott Laboratories | 4 | $80 |
| Exact Sciences Corporation | 4 | $79 |
| PFIZER INC. | 3 | $49 |
| Lilly USA, LLC | 3 | $48 |
| Amgen Inc. | 2 | $41 |
| SHIELD THERAPEUTICS INC | 1 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
Products named: Wegovy, Kerendia, QULIPTA, FREESTYLE LIBRE 3, Ozempic, UBRELVY, NURTEC ODT, MOUNJARO.
Industry payments across TX — which companies pay providers there.
